Related Experiment Video
Updated: Feb 20, 2026

10:01
Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain
Published on: October 25, 2017
11.8K
Modelling acrylamide acute neurotoxicity in zebrafish larvae
Eva Prats1, Cristian Gómez-Canela2, Shani Ben-Lulu3
1CID-CSIC, Jordi Girona 18, 08034, Barcelona, Spain.
Scientific Reports
|October 26, 2017
Summary
A new zebrafish model effectively mimics acrylamide (ACR) neurotoxicity, revealing damage to nerve terminals and neurotransmitter systems. This model is crucial for discovering new treatments for ACR-induced neuropathy.
Area of Science:
- Neuroscience
- Toxicology
- Developmental Biology
Background:
- Acrylamide (ACR) exposure causes neurotoxicity, including ataxia and muscle weakness.
- Current treatments are limited, necessitating novel therapeutic strategies.
- A robust model is needed to study ACR neurotoxicity and screen for effective compounds.
Purpose of the Study:
- To develop and validate a zebrafish model for acrylamide neurotoxicity.
- To investigate the pathological mechanisms of ACR-induced neuropathy in vivo.
- To establish a platform for identifying potential therapeutic agents against ACR toxicity.
Main Methods:
- Zebrafish larvae (5 days post-fertilization) were exposed to 1 mM acrylamide for 3 days.
- Behavioral assays were used to assess motor function.
- Immunohistochemistry, Western blotting, and neurotransmitter analysis were performed.
Main Results:
- The zebrafish model exhibited altered motor function and presynaptic nerve terminal damage.
- ACR-induced changes were observed in synaptic vesicle proteins and neurotransmitter systems (cholinergic and dopaminergic).
- Proteomic analysis confirmed acrylamide adducts on synaptic proteins.
Conclusions:
- The developed zebrafish model accurately recapitulates key features of human and mammalian acrylamide neurotoxicity.
- This model is suitable for high-throughput screening of potential therapeutic molecules.
- The findings provide insights into the molecular mechanisms underlying ACR-induced synaptopathy.

